Skip to main content
British Medical Journal logoLink to British Medical Journal
. 1959 Nov 14;2(5158):[969]-976-1, 977-980. doi: 10.1136/bmj.2.5158.969

Results of Treatment in Malignant Hypertension

M Harington, Priscilla Kincaid-Smith, J McMichael
PMCID: PMC1990728  PMID: 14399810

Full text

PDF

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BARNETT A. J. Treatment of severe arterial hypertension: results from long-term use of methonium compounds with and without the addition of reserpine. Australas Ann Med. 1956 Nov;5(4):274–290. doi: 10.1111/imj.1956.5.4.274. [DOI] [PubMed] [Google Scholar]
  2. CLARKE E., MURPHY E. A. Neurological manifestations of malignant hypertension. Br Med J. 1956 Dec 8;2(5005):1319–1326. doi: 10.1136/bmj.2.5005.1319. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. CORCORAN A. C., DUSTAN H. P., PAGE I. H., SCHNECKLOTH R. E. Mecamylamine in treatment of hypertensive disease; observations on an unusual neuromuscular complication. J Am Med Assoc. 1956 Oct 27;162(9):868–875. doi: 10.1001/jama.1956.02970260018006. [DOI] [PubMed] [Google Scholar]
  4. DEMING Q. B., HODES M. E., EDREIRA J. G., BALTAZAR A. Psychosis, possibly induced by mecamylamine. N Engl J Med. 1957 Apr 18;256(16):739–742. doi: 10.1056/NEJM195704182561604. [DOI] [PubMed] [Google Scholar]
  5. DUSTAN H. P., SCHNECKLOTH R. E., CORCORAN A. C., PAGE I. H. The effectiveness of long-term treatment of malignant hypertension. Circulation. 1958 Oct;18(4 Pt 1):644–651. doi: 10.1161/01.cir.18.4.644. [DOI] [PubMed] [Google Scholar]
  6. FRASER J. R., LOWE T. E. Fluid retention during methonium therapy. Australas Ann Med. 1954 Aug;3(3):234–237. doi: 10.1111/imj.1954.3.3.234. [DOI] [PubMed] [Google Scholar]
  7. HARINGTON M., KINCAID-SMITH P. Psychosis and tremor due to mecamylamine. Lancet. 1958 Mar 8;1(7019):499–501. doi: 10.1016/s0140-6736(58)90810-9. [DOI] [PubMed] [Google Scholar]
  8. HARINGTON M. The absorption and excretion of hexamethonium salts. Clin Sci. 1953 May;12(2):185–198. [PubMed] [Google Scholar]
  9. HILDEEN T., KROGSGAARD A. R., VIMTRUP B. Fatal pulmonary changes during the medical treatment of malignant hypertension. Lancet. 1958 Oct 18;2(7051):830–832. doi: 10.1016/s0140-6736(58)90380-5. [DOI] [PubMed] [Google Scholar]
  10. KINCAID-SMITH P., McMICHAEL J., MURPHY E. A. The clinical course and pathology of hypertension with papilloedema (malignant hypertension). Q J Med. 1958 Jan;27(105):117–153. [PubMed] [Google Scholar]
  11. KINCAID-SMITH P., SOMERS K., BROWNE J. C. M. Successful pregnancy under treatment for malignant hypertension. Lancet. 1958 Mar 8;1(7019):508–509. doi: 10.1016/s0140-6736(58)90814-6. [DOI] [PubMed] [Google Scholar]
  12. MASSON G. M., McCORMACK L. J., DUSTAN H. P., CORCORAN A. C. Hypertensive vascular disease as a consequence of increased arterial pressure; quantitative study in rats with hydralazine-treated renal hypertension. Am J Pathol. 1958 Sep-Oct;34(5):817–833. [PMC free article] [PubMed] [Google Scholar]
  13. McMICHAEL J., MURPHY E. A. Methonium treatment of severe and malignant hypertension. J Chronic Dis. 1955 May;1(5):527–535. doi: 10.1016/0021-9681(55)90064-3. [DOI] [PubMed] [Google Scholar]
  14. PERRY H. M., Jr, SCHROEDER H. A. The effect of treatment on mortality rates in severe hypertension; a comparison of medical and surgical regimens. AMA Arch Intern Med. 1958 Sep;102(3):418–425. doi: 10.1001/archinte.1958.00030010418011. [DOI] [PubMed] [Google Scholar]
  15. POUTASSE E. F., DUSTAN H. P. Arteriosclerosis and renal hypertension; indications for aortography in hypertensive patients and results of surgical treatment of obstructive lesions of renal artery. J Am Med Assoc. 1957 Nov 23;165(12):1521–1525. doi: 10.1001/jama.1957.02980300001001. [DOI] [PubMed] [Google Scholar]
  16. ROSENHEIM M. L. The treatment of severe hypertension. Br Med J. 1954 Nov 20;2(4898):1181–1193. doi: 10.1136/bmj.2.4898.1181. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. ROSS J. H., WRIGHT J. A. Successful twin pregnancy after treatment of malignant essential hypertension. Br Med J. 1958 Aug 30;2(5095):545–547. doi: 10.1136/bmj.2.5095.545. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. SCHOTTSTAEDT M. F., SOKOLOW M. The natural history and course of hypertension with papilledema (malignant hypertension). Am Heart J. 1953 Mar;45(3):331–362. doi: 10.1016/0002-8703(53)90147-1. [DOI] [PubMed] [Google Scholar]
  19. SMIRK F. H. Action of a new methonium compound in arterial hypertension; pentamethylene 1 : 5-bis-n-(n-methyl-pyrrolidinium) bitartrate (M. & B. 2050A). Lancet. 1953 Mar 7;1(6758):457–464. doi: 10.1016/s0140-6736(53)91640-7. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES